Life-threatening respiratory syncytial virus disease in children

Current Respiratory Medicine Reviews

Volumn 7, Issue 3, 2011, Pages 187-195

  Hennus, Marije P ^a   Bem, Reinout A ^b   Bos, Albert P ^b   van Vught, Adrianus J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Children; Intensive care unit; Life threatening; Mechanical ventilation; Respiratory syncytial virus infection

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; DEXAMETHASONE; EOSINOPHIL CATIONIC PROTEIN; GRANZYME; HELIOX; LUNG SURFACTANT; NITRIC OXIDE; PALIVIZUMAB; PLACEBO; RIBAVIRIN; VASOPRESSIN;

ACUTE LUNG INJURY; ACUTE RESPIRATORY FAILURE; ADAPTIVE IMMUNITY; ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY OBSTRUCTION; APNEA; APOPTOSIS; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; CELL ACTIVATION; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CHILDHOOD DISEASE; CYTOKINE RESPONSE; CYTOPATHOLOGY; DISEASE ASSOCIATION; DYSPHAGIA; EXTRACORPOREAL OXYGENATION; GASTROESOPHAGEAL REFLUX; GENETIC PREDISPOSITION; HIGH FREQUENCY VENTILATION; HISTOPATHOLOGY; HOST RESISTANCE; HUMAN; HUMAN METAPNEUMOVIRUS INFECTION; HYPONATREMIA; HYPOVENTILATION; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INAPPROPRIATE VASOPRESSIN SECRETION; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM; LUNG GAS EXCHANGE; LUNG LAVAGE; LUNG VENTILATION; LUNG VENTILATION PERFUSION RATIO; MECHANOTRANSDUCTION; MIXED INFECTION; MORTALITY; NONHUMAN; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SEROLOGY; SOMATIC HYPERMUTATION; THORAX RADIOGRAPHY; TRACHEAL ASPIRATION PROCEDURE; VIRAL BRONCHIOLITIS; VIRAL CLEARANCE; VIRUS ENTRY; VIRUS REPLICATION;

EID: 79956273893     PISSN: 1573398X     EISSN: 18756387     Source Type: Journal    
DOI: 10.2174/157339811795589513     Document Type: Article

References (132)

1. Glezen P, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973; 288: 498-505.
2. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140: 543-6.
3. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006; 118: 1774-93.
4. Behrendt CE, Decker MD, Burch DJ, Watson PH. International variation in the management of infants hospitalized with respiratory syncytial virus. Eur J Pediatr. 1998; 157: 215-20.
5. Simoes EAF. Respiratory syncytial virus infection. Lancet 1999; 354: 847-52.
6. Dahlem P, van Aalderen WM, Hamaker ME, Dijkgraaf MG, Bos AP. Incidence and short-term outcome of acute lung injury in mechanically ventilated children. Eur Respir J 2003; 22: 980-5.
7. Erickson S, Schibler A, Numa A, et al. Acute lung injury in pediatric intensive care in Australia and New Zealand: a prospective, multicenter, observational study. Pediatr Crit Care Med 2007; 8: 317-23.
8. Zimmerman JJ, Akhtar SR, Caldwell E, Rubenfeld GD. Incidence and outcomes of pediatric acute lung injury. Pediatrics 2009; 124: 87-95.
9. Aherne W, Bird T, Court SD, Gardner PS, McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970; 23: 7-18.
10. Reed JL, Brewah YA, Delaney T, et al. Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis. J Infect Dis 2008; 198: 1783-93.
11. Welliver TP, Garofalo RP, Hosakote Y, et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 2007; 195: 1126-36.
12. Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 2007; 20: 108-19.
13. Hosakote YM, Liu T, Castro SM, Garofalo RP, Casola A. Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes. Am J Respir Cell Mol Biol 2009; 41: 348-57.
14. Viuff B, Tjornehoj K, Larsen LE, et al. Replication and clearance of respiratory syncytial virus: apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus. Am J Pathol 2002; 161: 2195-207.
15. Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 2002; 76: 5654-66.
16. Chen L, Song W, Davis IC, et al. Inhibition of Na+ transport in lung epithelial cells by respiratory syncytial virus infection. Am J Respir Cell Mol Biol 2009; 40: 588-600.
17. Davis IC, Lazarowski ER, Hickman-Davis JM, et al. Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus. Am J Respir Crit Care Med 2006; 173: 673-82.
18. Singh D, McCann KL, Imani F. MAPK and heat shock protein 27 activation are associated with respiratory syncytial virus induction of human bronchial epithelial monolayer disruption. Am J Physiol Lung Cell Mol Physiol 2007; 293: L436-45.
19. Tripp RA, Moore D, Jones L, Sullender W, Winter J, Anderson LJ. Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J Virol 1999; 73: 7099-107.
20. Bem RA, Bos AP, Bots M, et al. Activation of the granzyme pathway in children with severe respiratory syncytial virus infection. Pediatr Res 2008; 63: 650-5.
21. Lukens MV, van de Pol AC, Coenjaerts FE, et al. A systemic neutrophil response precedes robust CD8+ T cell activation during natural respiratory syncytial virus infection in infants. J Virol 2010; 84: 2367-83.
22. DeVincenzo JP, El Saleeby CM, Bush AJ. Respiratory Syncytial Virus Load Predicts Disease Severity in Previously Healthy Infants. J Infect Dis 2005; 191: 1861-8.
23. van Woensel JB, Lutter R, Biezeveld MH, et al. Effect of dexamethasone on tracheal viral load and interleukin-8 tracheal concentration in children with respiratory syncytial virus infection. Pediatr Infect Dis J 2003; 22: 721-6.
24. Bont L, Heijnen CJ, Kavelaars A, et al. Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis 2001; 184: 355-8.
25. McNamara PS, Flanagan BF, Hart CA, Smyth RL. Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 2005; 191: 1225-32.
26. Everard ML, Swarbrick A, Wrightham M, et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 1994; 71: 428-32.
27. Jones A, Qui JM, Bataki E, Elphick H, Ritson S, Evans GS. Neutrophil survival is prolonged in the airways of healthy infants and infants with RSV bronchiolitis. Eur Respir J 2002; 20: 651-7.
28. Moraes TJ, Zurawska JH, Downey GP. Neutrophil granule contents in the pathogenesis of lung injury. Curr Opin Hematol 2006; 13: 21-7.
29. Repine JE, Beehler CJ. Neutrophils and Adult Respiratory Distress Syndrome: Two Interlocking Perspectives in 1991. Am Rev Respir Dis 1991; 144: 251-2.
30. Wang SZ, Forsyth KD. The interaction of neutrophils with respiratory epithelial cells in viral infection. Respirology 2000; 5: 1-10.
31. Serrao KL, Fortenberry JD, Owens ML, Harris FL, Brown LA. Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am J Physiol Lung Cell Mol Physiol 2001; 280: L298-305.
32. Tecchio C, Huber V, Scapini P, et al. IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 Ligand) displaying apoptotic activity on leukemic cells. Blood 2004; 103: 3837-44.
33. Bem RA, Bos AP, Wosten-van Asperen RM, et al. Potential role of soluble TRAIL in epithelial injury in children with severe RSV infection. Am J Respir Cell Mol Biol 201; 42(6): 697-705.
34. Matute-Bello G, Liles WC, Steinberg KP, et al. Soluble fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 1999; 163: 2217-25.
35. Harrison AM, Bonville CA, Rosenberg HF, Domachowske JB. Respiratory syncytical virus-induced chemokine expression in the lower airways: Eosinophil recruitment and degranulation. Am J Respir Crit Care Med 1999; 159: 1918-24.
36. Bem RA, van Woensel JB, Lutter R, et al. Granzyme A- and B- cluster deficiency delays acute lung injury in pneumovirus-infected mice. J Immunol 2010; 184: 931-8.
37. Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 1991; 88: 1026-33.
38. Frey S, Krempl CD, Schmitt-Graff A, Ehl S. Role of T cells in virus control and disease after infection with pneumonia virus of mice. J Virol 2008; 82: 11619-27.
39. Domachowske JB, Bonville CA, Rosenberg HF. Animal models for studying respiratory syncytial virus infection and its long term effects on lung function. Pediatr Infect Dis J 2004; 23: S228-34.
40. DeVincenzo JP. Natural infection of infants with respiratory syncytial virus subgroups A and B: a study of frequency, disease severity, and viral load. Pediatr Res 2004; 56: 914-7.
41. Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981; 98: 708-15.
42. Walsh EE, McConnochie KM, Long CE, Hall CB. Severity of respiratory syncytial virus infection is related to virus strain. J Infect Dis 1997; 175: 814-20.
43. Amanatidou V, Apostolakis S, Spandidos DA. Genetic diversity of the host and severe respiratory syncytial virus-induced lower respiratory tract infection. Pediatr Infect Dis J 2009; 28: 135-40.
44. Miyairi I, DeVincenzo JP. Human genetic factors and respiratory syncytial virus disease severity. Clin Microbiol Rev 2008; 21: 686-703.
45. Hall CB, Weinberg GA, Iwane MK, et al. The Burden of Respiratory Syncytial Virus Infection in Young Children. N Engl J Med 2009; 360: 588-98.
46. Hall CB, Kopelman AE, Douglas RG Jr, Geiman JM, Meagher MP. Neonatal respiratory syncytial virus infection. N Engl J Med 1979; 300: 393-6.
47. Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 2000; 137: 865-70.
48. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995; 126: 212-9.
49. Piedra PA, Grace S, Jewell A, et al. Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. Pediatr Infect Dis J 1996; 15: 23-31.
50. MacDonald NE, Hall CB, Suffin SC, Alexson C, Harris PJ, Manning JA. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 1982; 307: 397-400.
51. Fishaut M, Tubergen D, McIntosh K. Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J Pediatr 1980; 96: 179-86.
52. Hall CB, Powell KR, MacDonald NE, et al. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 1986; 315: 77-81.
53. Bont LJ, Kimpen JL. Immunological mechanisms of severe respiratory syncytial virus bronchiolitis. Intensive Care Med 2002; 28: 616-21.
54. Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr 2003; 143: S112-7.
55. Bloemers BL, van Furth AM, Weijerman ME, et al. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis--a prospective birth-cohort study. Pediatrics 2007; 120: e1076-81.
56. Wilkesmann A, Ammann RA, Schildgen O, et al. Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course. Pediatr Infect Dis J 2007; 26: 485-91.
57. Resch B, Manzoni P, Lanari M. Severe respiratory syncytial virus (RSV) infection in infants with neuromusculair diseases and immune deficiency syndromes. Paediatr Respir Rev 2009; 10: 148-53.
58. McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002; 346: 429-37.
59. Saijo M, Ishii T, Kokubo M, et al. White blood cell count, C- reactive protein and erythrocyte sedimentation rate in respiratory syncytial virus infection of the lower respiratory tract. Acta Paediatr Jpn 1996; 38: 596-600.
60. Kneyber MC, Blusse vO-A, van VM, Uiterwaal CS, Kimpen JL, van Vught AJ. Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease. Intensive Care Med 2005; 31: 680-5.
61. Levin D, Tribuzio M, Green-Wrzesinki T, Ames B, Radwan S, Jarvis JD. Empiric Antibiotics Are Justified for Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection Presenting With Respiratory Failure: A Prospective Study and Evidence Review. Pediatr Crit Care Med 2010; 11(3): 390-5.
62. Thorburn K, Harigopal S, Reddy V, Taylor N, van Saene HK. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax 2006; 61: 611-5.
63. Richard N, Komurian-Pradel F, Javouhey E, et al. The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr Infect Dis 2008; 27: 213-7.
64. van de Pol AC, van Loon AM, Wolfs TF, Jansen NJ, Nijhuis M, Breteler EK. Increased detection of respiratory syncytial virus, influenza viruses, parainfluenza viruses, and adenoviruses with real-time PCR in samples from patients with respiratory symptoms. J Clin Microbiol 2007; 45: 2260-2.
65. Freymuth F, Vabret A, Cuvillon-Nimal D, et al. Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness. J Med Virol 2006; 78: 1498-504.
66. McNamara PS, Flanagan BF, Smyth RL, Hart CA. Impact of human metapneumovirus and respiratory syncytial virus co- infection in severe bronchiolitis. Pediatr Pulmonol 2007; 42: 740-3.
67. Aberle JH, Aberle SW, Hutter HP, et al. Single virus versus dual respiratory virus infections in hospitalized infants. Impact on clinical course of disease and interferon-c response. Pediatr Infect Dis J 2005; 24: 605-10.
68. Xepapadaki P, Psarras S, Bossios A, et al. Human metapneumovirus as a causative agent of acute bronchiolitis in infants. J Clin Virol 2004; 30: 267-70.
69. Papadopoulos NG, Moustaki M, Tsolia M, et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med 2002; 165: 1285-99.
70. Willson DF, Landrigan CP, Horn SD, Smout RJ. Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia. J Pediatr 2003; 143: S142-9.
71. Hanna S, Tibby SM, Durward A, Murdoch IA. Incidence of hyponatraemia and hyponatraemic seizures in severe respiratory syncytial virus bronchiolitis. Acta Paediatr 2003; 92: 430-4.
72. van Steensel-Moll HA, Hazelzet JA, Vander Voort E, Neijens HJ, Hackeng WHL. Excessive secretion of antidiuretic hormone in infections with respiratory syncytial virus. Arch Dis Child 1990; 65: 1237-9.
73. Kneyber MC, Brandenburg AH, de GR, Joosten KF, Rothbarth PH, Ott A. Risk Factors for Respiratory Syncytial Virus Associated Apnoea. Eur J Pediatr 1998; 157: 331-5.
74. Rayyan M, Naulaers G, Daniels H, Allegaert K, Debeer A, Devlieger H. Characteristics of Respiratory Syncytial Virus- Related Apnoea in Three Infants. Acta Paediatr 2004; 93: 847-9.
75. Lindgren C, Lin J, Graham BS, Gray ME, Parker RA, Sundell HW. Respiratory Syncytial Virus Infection Enhances the Response to Laryngeal Chemostimulation and Inhibits Arousal From Sleep in Young Lambs. Acta Paediatr 1996; 85:789-97.
76. Tripp RA, Dakhama A, Jones LP, Barskey A, Gelfand EW, Anderson LJ. The G Glycoprotein of Respiratory Syncytial Virus Depresses Respiratory Rates Through the CX3C Motif and Substance P. J Virol 2003; 77: 6580-4.
77. Anas, N, Boettrich, C, Hall, CB, Brooks, JG. The association of apnea and respiratory syncytial virus infection in infants. J Pediatr 1982; 101: 65-8.
78. Lindgren C, Jing L, Graham B, et al. Respiratory syncytial virus infection reinforces reflex apnea in young lambs. Pediatr Res 1992; 31: 381-5.
79. Bruhn, F, Mokrohisky, ST, McIntosh K. Apnea associated with respiratory syncytial virus infection in young infants. J Pediatr 1977; 90: 382-6.
80. Flores G, Horwitz RI. Effi cacy of beta-2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 1997; 100: 233-9.
81. Gadomski AM, Bhasale AL. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2006; 3:CD001266
82. Hammer J, Numa A, Newth C. Albuterol responsiveness in infants with respiratory failure caused by respiratory syncytial virus infection. J Pediatr 1995; 127: 485-7.
83. Langley JM, Smith MB, LeBlanc JC, et al. Racemic epinephrine compared to salbutamol in hospitalized young children with bronchiolitis; a randomized controlled clinical trial. BMC Pediatr 2005; 5: 7.
84. Levin DL, Garg A, Hall LJ, Slogic S, Jarvis JD, Leiter JC. A prospective randomized controlled blinded study of three bronchodilators in infants with respiratory syncytial virus bronchiolitis on mechanical ventilation. Pediatr Crit Care Med. 2008; 9: 598-604.
85. Patel, H, Platt, R, Lozano, J, Wang, E. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2004; 3:CD004878.
86. Cade A, Brownlee KG, Conway SP, et al. Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child 2000; 82: 126-30.
87. King VJ, Viswanathan M, Bordley WC, et al. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med 2004; 158: 127-37.
88. Buckingham SC, Jafri HS, Bush AJ, Carubelli CM, Sheeran P, Hardy RD. A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome. J Infect Dis 2002 1; 185:1222-8.
89. van Woensel JB, van Aalderen WM, de Weerd W, Jansen NJ, van Gestel JP, Markhorst DG. Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax 2003; 58: 383-7.
90. Somers CC, Ahmad N, Mejias A, Buckingham SC, Carubelli C, Katz K. Effect of dexamethasone on respiratory syncytial virus- induced lung inflammation in children: results of a randomized, placebo controlled clinical trial. Pediatr Allergy Immunol 2009; 20: 477-85.
91. Ventre K, Randolph A. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev 2007; CD000181.
92. Fuller H, Del Mar C. Immunoglobulin treatment for respiratory syncytial virus infection. Cochrane Database Syst Rev 2006; CD004883.
93. Patel NR, Hammer J, Nichani S, Numa A, Newth CJ. Effect of inhaled nitric oxide on respiratory mechanics in ventilated infants with RSV bronchiolitis. Intensive Care Med 1999; 25:81-7.
94. Sokol J, Jacobs SE, Bohn D. Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults. Cochrane Database Syst Rev 2003; (1): CD002787.
95. Fitzgerald D, Davis GM, Rohlicek C, Gottesman R. Quantifying pulmonary hypertension in ventilated infants with bronchiolitis: A pilot study. J Paediatr Child Health 2001; 37: 64-6.
96. Skelton R, Holland P, Darowski M, Chetcuti PA, Morgan LW, Harwood JL. Abnormal surfactant composition and activity in severe bronchiolitis. Acta Paediatr 1999; 88: 942-6.
97. Van Schaik SM, Vargas I, Welliver RC, et al. Surfactant dysfunction develops in BALB/c mice infected with respiratory syncytial virus. Pediatr Res 1997; 42: 169-73.
98. Lachmann B, Hallman M, Bergmann KC. Respiratory failure following anti-lung serum: Study on mechanisms associated with surfactant system damage. Exp Lung Res 1987; 12: 163-80.
99. Veldhuizen RAW, Ito Y, Marcou J, et al. Effects of lung injury on pulmonary surfactant aggregate conversion in vivo and in vitro. Am J Physiol 1997; 72: L872-8.
100. Dargaville PA, South M, McDougall PN. Surfactant abnormalities in infants with severe viral bronchiolitis. Arch Dis Child 1996; 75:133-6
101. Tibby SM, Hatherill M, Wright SM, Wilson P, Postle AD, Murdoch IA. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2000; 162: 1251-6.
102. Luchetti M, Ferrero F, Gallini C, Natale A, Pigna A, Tortorolo L. Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatr Crit Care Med 2002; 3: 261-8.
103. Kneyber MC, van Heerde M, Twisk JW, Plötz FB, Markhorst DG. Heliox reduces respiratory system resistance in respiratory syncytial virus induced respiratory failure. Crit Care 2009; 13(3): R71.
104. Gross MF, Spear RM, Peterson BM. Helium-oxygen mixture does not improve gas exchange in mechanically ventilated children with bronchiolitis. Crit Care 2000; 4:188-92.
105. Martinón-Torres F, Rodríguez-Núñez A, Martinón-Sánchez JM. Nasal continuous positive airway pressure with heliox versus air oxygen in infants with acute bronchiolitis: a crossover study. Pediatrics 2008; 121: e1190-5.
106. Lebel MH, Gauthier M, Lacroix J, et al. Respiratory failure and mechanical ventilation in severe bronchiolitis. Arch Dis Child 1989; 64: 431-7.
107. Leclerc F, Scalfaro P, Noizet O, Thumerelle C, Dorkenoo A, Fourier C. Mechanical ventilatory support in infants with respiratory syncytial virus infection. Pediatr Crit Care Med 2001; 2: 197-204.
108. Greenough A. Role of ventilation in RSV disease: CPAP, ventilation, HFO, ECMO. Paediatr Respir Rev 2009; 10: 26-8.
109. Milesi C, Cambonie G, Barbotte E, Jacquot A, Jaber S, Picaud JC. Effects of nasal continuous positive airway pressure (CPAP) on respiratory muscles work and respiratory distress symptoms in severe acute bronchiolitis. Pediatr Crit Care Med 2007; Suppl 8: A264.
110. Cambonie G, Milési C, Jaber S, Amsallem F, Barbotte E, Picaud JC. Nasal continuous positive airway pressure decreases respiratory muscles overload in young infants with severe acute viral bronchiolitis. Intensive Care Med 2008; 34: 1865-72.
111. Thia LP, McKenzie SA, Blyth TP, Minasian CC, Kozlowska WJ, Carr SB. Randomised controlled trial of nasal continuous positive airways pressure (CPAP) in bronchiolitis. Arch Dis Child. 2008; 93: 45-7.
112. Cambonie G, Guillaumont S, Luc F, Vergnes C, Milesi C, Voisin M. Haemodynamic features during high frequency oscillatory ventilation in preterms. Acta Paediatr 2003; 92: 1068-73.
113. Javouhey E, Barats A, Richard N, Stamm D, Floret D. Non- invasive ventilation as primary ventilatory support for infants with severe bronchiolitis. Intensive Care Med 2008; 34: 1608-14.
114. ARDS Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The acute respiratory distress syndrome network N Engl J Med 2000; 342: 1301-8.
115. Dreyfuss D, Saumon G. Ventilator-induced lung injury: Lessons from experimental studies. Am J Respir Crit Care Med 1998; 157: 294-323.
116. Tremblay LN, Slutsky AS. Ventilator-induced lung injury: From the bench to the bedside. Intensive Care Med 2006; 32: 24-33.
117. Vlahakis NE, Hubmayr RD. Cellular stress failure in ventilator- injured lungs. Am J Respir Crit Care Med 2005; 171: 1328-42.
118. Pugin J, Dunn I, Jolliet P, Tassaux D, Magnenat JL, Nicod LP. Activation of human macrophages by mechanical ventilation in vitro. Am J Physiol 1998; 275: L1040-50.
119. Altemeier WA, Matute-Bello G, Frevert CW, Kawata Y, Kajikawa O, Martin TR. Mechanical ventilation with moderate tidal volumes synergistically increases lung cytokine response to systemic endotoxin. Am J Physiol Lung Cell Mol Physiol 2004; 287: L533-42.
120. Altemeier WA, Matute-Bello G, Gharib SA, Glenny RW, Martin TR, Liles WC. Modulation of lipopolysaccharide-induced gene transcription and promotion of lung injury by mechanical ventilation. J Immunol 2005; 175: 3369-76.
121. Dhanireddy S, Altemeier WA, Matute-Bello G, O'Mahony DS, Glenny RW, Martin TR. Mechanical ventilation induces inflammation, lung injury, and extra-pulmonary organ dysfunction in experimental pneumonia. Lab Invest 2006; 86: 790-9.
122. Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS. Injurious ventilatory strategies increase cytokines and C-Fos M-RNA expression in an isolated rat lung model. J Clin Invest 1997; 99: 944-52.
123. Bem RA, van Woensel JB, Bos AP, Koski A, Farnand AW, Domachowske JB. Mechanical Ventilation Enhances Lung Inflammation and Caspase Activity in a Model of Mouse Pneumovirus Infection. Am J Physiol Lung Cell Mol Physiol 2009; 296: L46-56.
124. Arnold JH, Truog RD, Thompson JE, Fackler JC. High-frequency oscillatory ventilation in pediatric respiratory failure. Crit Care Med 1993; 21: 272-8.
125. Kinsella JP, Clark RH. High-frequency oscillatory ventilation in pediatric critical care. Crit Care Med 1993; 21: 174-5.
126. Berner ME, Hanquinet S, Rimensberger PC. High frequency oscillatory ventilation for respiratory failure due to RSV bronchiolitis. Intensive Care Med 2008; 34: 1698-702.
127. Duval ELIM, Leroy PLJM, Gemke RJBJ, Van Vught AJ. Highfrequency oscillatory ventilation in RSV bronchiolitis patients. Respir Med 1999; 93: 435-40.
128. Steinhorn RH, Green TP. Use of extracorporeal membrane oxygenation in the treatment of respiratory syncytial virus bronchiolitis: the national experience, 1983 to 1988. J Pediatr 1990; 116: 338-42.
129. Flamant C, Hallalel F, Nolent P, Chevalier JY, Renolleau S. Severe respiratory syncytial virus bronchiolitis in children: from short mechanical ventilation to extracorporeal membrane oxygenation. Eur J Pediatr 2005; 164: 93-8.
130. Khan JY, Kerr SJ, Tometzki A, et al. Role of ECMO in the treatment of respiratory syncytial virus bronchiolitis: a collaborative report. Arch Dis Child Fetal Neonatal Ed 1995; 73: F91-4.
131. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995; 126: 212-9.
132. Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child 2009; 94: 99-103.